FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

787994008: Antibacterial therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778326014 Antibacterial therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3778327017 Antibacterial therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antibacterial therapeutic role Is a Therapeutic role false Inferred relationship Existential restriction modifier
Antibacterial therapeutic role Is a Antiinfective therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing norfloxacin and tinidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only norfloxacin and tinidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing norfloxacin and tinidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ofloxacin and ornidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ofloxacin and ornidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ofloxacin and ornidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ofloxacin and ornidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfasalazine 1 gram/1 each gastro-resistant oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing clobetasol and gentamicin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing clobetasol and gentamicin in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only clobetasol and gentamicin in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only clobetasol and gentamicin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only furazolidone in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing furazolidone in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely furazolidone 6 milligram/1 milliliter and metronidazole (as metronidazole benzoate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing furazolidone and metronidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only furazolidone and metronidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only furazolidone and metronidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing furazolidone and metronidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine gluconate 2.5 milligram/1 gram and metronidazole 10 milligram/1 gram conventional release dental gel (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing chlorhexidine and metronidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only chlorhexidine and metronidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing chlorhexidine and metronidazole in dental dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only chlorhexidine and metronidazole in dental dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing lidocaine and metronidazole and sucralfate (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only lidocaine and metronidazole and sucralfate (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely framycetin sulfate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing framycetin in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only framycetin in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin dihydrate 15 milligram/1 gram conventional release eye drops (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin 10 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 25 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely avibactam (as avibactam sodium) 500 milligram and ceftazidime 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely plazomicin (as plazomicin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely furazolidone 100 milligram and metronidazole 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin sodium) 8 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only fosfomycin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing fosfomycin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 5 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 250 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 80 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 60 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely meropenem 1 gram and vaborbactam 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin (as cloxacillin sodium) 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin (as cloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin (as cloxacillin sodium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 2.4 million unit/1 vial powder for conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amikacin sulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing amikacin in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only amikacin in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol (as chloramphenicol palmitate) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotaxime (as cefotaxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin (as cloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin (as cloxacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin (as cloxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin (as cloxacillin sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 10 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely spectinomycin (as spectinomycin hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely linezolid 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefatrizine (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefatrizine in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefatrizine (as cefatrizine propylene glycolate) 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefatrizine (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefatrizine in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram and tinidazole 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ciprofloxacin and tinidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ciprofloxacin and tinidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ciprofloxacin and tinidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ciprofloxacin and tinidazole in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefixime 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amikacin (as amikacin sulfate) 125 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftriaxone (as ceftriaxone sodium) 1 gram and sulbactam (as sulbactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ceftriaxone and sulbactam (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ceftriaxone and sulbactam (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ceftriaxone and sulbactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ceftriaxone and sulbactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 20 of 27 Next End

This concept is not in any reference sets

Back to Start